Company Filing History:
Years Active: 2016-2024
Title: Romain Ollier: Innovator in Immunology
Introduction
Romain Ollier is a prominent inventor based in La Chaux-de-Fonds, Switzerland. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of six patents to his name, Ollier's work focuses on advancing therapeutic and diagnostic methods.
Latest Patents
Ollier's latest patents include groundbreaking inventions such as CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production. This invention relates to hetero-dimeric immunoglobulins that target both a component of the human CD3 antigen and a component of the human CD38 antigen. Additionally, it encompasses antibodies that bind to the human CD38 antigen and derivatives for use as therapeutic or diagnostic reagents. Another notable patent is the production of T cell retargeting hetero-dimeric immunoglobulins, which describes engineered immunoglobulins that bind to CD3 and disease-associated antigens. These immunoglobulins are designed to promote hetero-dimer formation during expression and can be purified using a Protein A differential purification technique.
Career Highlights
Throughout his career, Romain Ollier has worked with notable companies such as Ichnos Sciences SA and Glenmark Pharmaceuticals SA. His experience in these organizations has contributed to his expertise in the field of immunology and patent development.
Collaborations
Ollier has collaborated with several professionals in his field, including Samuel Hou and Darko Skegro. These collaborations have likely enhanced his research and innovation efforts.
Conclusion
Romain Ollier is a distinguished inventor whose work in immunology has led to significant advancements in therapeutic and diagnostic methods. His innovative patents reflect his commitment to improving healthcare through scientific research and development.